Business

Our writer unpacks the data behind the new vaccines and wonders what happened to nuance in the CDC’s recommendations.

How DeSci, DAOs, and NFTs will change research funding, intellectual property, and collaboration.

Workforce diversity, collective oversight, and day-to-day algorithm monitoring are all necessary to mitigate inherent bias.

Roswell Biotechnologies wants you to believe its new chip will revolutionize the detection of viruses, DNA, and more. But it still has to prove itself.

Microbiome research has huge implications for the very sick. But can startups get healthy people in on the action?

Corporate America is embracing mindfulness more than ever as the pandemic rages. But what do they mean by “mindfulness,” and does it work?

We ask the experts what’s coming in the next 12 months.

The aspects that make them most creative may also be their biggest risk.

Can we thwart Beijing’s drive for U.S. secrets without stifling science or harming American innovation?

Major corporations are applying the lessons of cognitive neuroscience to get the American public buying.